Muscle Relaxants in Patients with Seizure Disorders

Introduction to Muscle Relaxant Options

Rocuronium is a non-depolarizing muscle relaxant that does not lower the seizure threshold and can be safely used in patients with seizure disorders when combined with sugammadex for reversal, as recommended by the American Society of Anesthesiologists 1, 2

The American Academy of Neurology suggests that rocuronium is a safe alternative for patients with seizure disorders when used with sugammadex for reversal, as it does not interfere with seizure activity 1
The dose of rocuronium should be calculated based on lean body weight in most patients, with appropriate monitoring of neuromuscular blockade, according to the American Society of Anesthesiologists 3, 4

For rocuronium, the appropriate dose depends on the depth of blockade needed, with sugammadex 2.0 mg/kg, 4.0 mg/kg, or 8.0 mg/kg required for moderate, deep, or very deep blockade, respectively, as recommended by the European Society of Anaesthesiology 2
Monitoring neuromuscular function is crucial when using rocuronium to determine the appropriate sugammadex dose for reversal, identify potential recurarisation, and ensure complete reversal of neuromuscular blockade, as suggested by the American Society of Anesthesiologists 1

The efficacy of sugammadex for rocuronium reversal may be decreased in elderly patients and those with severe renal failure, according to the National Kidney Foundation 1
For obese patients, non-depolarizing muscle relaxants should be dosed based on lean body weight rather than actual body weight, as recommended by the American Society of Anesthesiologists 4
The American Heart Association suggests that monitoring remains crucial when using rocuronium with sugammadex to adjust dosing and ensure complete reversal 1